Literature DB >> 16843635

Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma.

I J Park1, H C Kim, C S Yu, M H Ryu, H M Chang, J H Kim, J S Ryu, J S Yeo, J C Kim.   

Abstract

AIM: This study was performed to assess in the accurate evaluation of primary colorectal carcinoma using PET/CT.
METHODS: One hundred patients with primary colorectal carcinoma were evaluated during 2004. All patients underwent PET/CT when their preoperative serum carcinoembryonic antigen was >or=10 ng/mL or when CT showed equivocal findings. The appropriateness of PET/CT-induced changes was noted by subsequent operative findings and follow-up.
RESULTS: PET/CT more detected 15 intra-abdominal metastatic lesions than abdomino-pelvic CT scan. PET/CT showed true negative findings in 13 patients and false positive or negative findings in 10. Due to PET/CT results, management plans were altered in 27 patients; 9 had inter-modality changes, 10 received more extensive surgery, and 8 avoided unnecessary procedures.
CONCLUSIONS: PET/CT altered management plan in 24% of patients with primary colorectal carcinoma in correct direction. These findings suggest that PET/CT should be considered a part of standard work up for preoperative evaluation in a subset of patients with colorectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16843635     DOI: 10.1016/j.ejso.2006.05.019

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  17 in total

Review 1.  Positron emission tomography for benign and malignant disease.

Authors:  Anthony Visioni; Julian Kim
Journal:  Surg Clin North Am       Date:  2011-02       Impact factor: 2.741

2.  Diagnostic performance of ¹⁸F-fluorothymidine PET/CT for primary colorectal cancer and its lymph node metastasis: comparison with ¹⁸F-fluorodeoxyglucose PET/CT.

Authors:  Masatoyo Nakajo; Masayuki Nakajo; Yoriko Kajiya; Megumi Jinguji; Nobuaki Nishimata; Shunji Shimaoka; Tohru Nihara; Kuniaki Aridome; Sadao Tanaka; Yoshihiko Fukukura; Atushi Tani; Chihaya Koriyama
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-08       Impact factor: 9.236

3.  Positron emission tomography/computed tomography in the staging of colon cancer.

Authors:  Jae Hyung Lee; Min Ro Lee
Journal:  Ann Coloproctol       Date:  2014-02-28

4.  Clinical impact of FDG-PET/CT on colorectal cancer staging and treatment strategy.

Authors:  Rasmus K Petersen; Søren Hess; Abass Alavi; Poul F Høilund-Carlsen
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-08-15

5.  Role of the standardized uptake value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in detecting the primary tumor and lymph node metastasis in colorectal cancers.

Authors:  Shuichiro Uchiyama; Yukihiro Haruyama; Takashi Asada; Masayuki Hotokezaka; Shigeki Nagamachi; Kazuo Chijiiwa
Journal:  Surg Today       Date:  2012-06-19       Impact factor: 2.549

6.  Diagnostic value of FDG-PET/CT for lymph node metastasis of colorectal cancer.

Authors:  Jae Young Kwak; Jae Seung Kim; Hye Jin Kim; Hyun Kwon Ha; Chang Sik Yu; Jin Cheon Kim
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

Review 7.  Epidemiology and management options for colorectal cancer in children.

Authors:  Raya Saab; Wayne L Furman
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

8.  Pre-operative TNM staging of primary colorectal cancer by (18)F-FDG PET-CT or PET: a meta-analysis including 2283 patients.

Authors:  Yanwei Ye; Tao Liu; Lisha Lu; Guojun Wang; Min Wang; Jingjing Li; Chao Han; Jianguo Wen
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 9.  Colonography by CT, MRI and PET/CT combined with conventional colonoscopy in colorectal cancer screening and staging.

Authors:  Long Sun; Hua Wu; Yong-Song Guan
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

10.  Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method.

Authors:  Rafke Schoffelen; Winette Ta van der Graaf; Robert M Sharkey; Gerben M Franssen; William J McBride; Chien-Hsing Chang; Peter Laverman; David M Goldenberg; Wim Jg Oyen; Otto C Boerman
Journal:  EJNMMI Res       Date:  2012-01-27       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.